Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Prophylaxis in TTP
NCT05568147Phase 3Not yet recruiting
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Oct 2022
- Primary completion
- Sep 2027
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of aspirin in thrombotic thrombocytopenic purpura (TTP), sponsored by First Affiliated Hospital of Soochow University. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
aspirin
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT05568147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05568147.